Guaifenesin And Pseudoephedrine Hcl Tablet, Extended Release
Product Images NDC 51660-074

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Guaifenesin And Pseudoephedrine Hcl (NDC 51660-074). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ohm Laboratories, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Guaif-pseuso (Guaifenesin Pseudo 01)

FDA Label Image

Guai-pseudo-02 (Guaifenesin Pseudo 02)

Guai-pseudo-02 (Guaifenesin Pseudo 02)
This text is a detailed description of Guaifenesin Extended-Release Tablets, which are used as an expectorant and nasal decongestant. The tablets provide relief from nasal/sinus congestion, help thin and loosen mucus, and offer immediate and extended release. The product is comparable to Maximum Strength Mucinex D and contains active ingredients like Guaifenesin and Pseudoephedrine HCI. It includes drug facts, active ingredient information, directions for use, warnings, and storage instructions. Additionally, it provides details on when to consult a doctor, how to handle overdoses, and contact information for further inquiries. The product is distributed by Ohm Laboratories and has an expiration date mentioned in the text.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.